Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapyBeth L. Thurberg, M. W. O'CALLAGHAN, A. Bernard Collins et al.|Kidney International|2002Cited by 331
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in DogsDavid L. Mack, Martin K. Childers, Karine Poulard et al.|Molecular Therapy|2017Cited by 109
Biochemical and pharmacological characterization of different recombinant acid α-glucosidase preparations evaluated for the treatment of Pompe diseaseAlison McVie‐Wylie, Robert J. Mattaliano, Nina Raben et al.|Molecular Genetics and Metabolism|2008Cited by 96
Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathyMichael W. Lawlor, Alan H. Beggs, Dustin Armstrong et al.|Human Molecular Genetics|2013Cited by 82